Literature DB >> 8235999

Basal cell carcinoma of the eyelid and periocular skin.

C E Margo1, K Waltz.   

Abstract

Basal cell carcinoma is the most common human malignancy. This locally invasive tumor rarely metastasizes, but can cause considerable morbidity when on the eyelids and periocular skin. The successful management of BCC requires an awareness of its broad clinical spectrum and knowledge of the risk factors associated with therapeutic failure. The optimal therapy for basal cell carcinoma is controversial. Treatment strategy is formulated on an individual basis, taking into account tumor size, anatomic location, and growth pattern. The immune status and life expectancy of the patient also must be considered. While complete eradication of the tumor is desirable, this can be challenging since basal cell carcinomas often extend beyond their apparent clinical margins. Since prevention is preferable to treatment, the public needs to be informed that the incidence of periocular skin cancers can be reduced with the longterm use of sunscreens, sunglasses, and hats with brims.

Entities:  

Mesh:

Year:  1993        PMID: 8235999     DOI: 10.1016/0039-6257(93)90100-l

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  26 in total

1.  Long-term results after surgical basal cell carcinoma excision in the eyelid region.

Authors:  S Pieh; A Kuchar; P Novak; R Kunstfeld; G Nagel; F J Steinkogler
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

2.  Clinicopathologic features and prognostic factors of malignant eyelid tumors.

Authors:  Chang-Jun Wang; Hui-Na Zhang; Han Wu; Xin Shi; Jia-Jun Xie; Jin-Jing He; Koung-Hoon Kook; Sang-Yeul Lee; Juan Ye
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

3.  Confident complete excision of lid-margin BCCs using a marginal strip: an alternative to Mohs' surgery.

Authors:  Narendra Dhingra; Adam Gajdasty; Jim W Neal; Achyut N Mukherjee; Carol M Lane
Journal:  Br J Ophthalmol       Date:  2007-01-17       Impact factor: 4.638

4.  Primary basal cell carcinoma of the caruncle with seeding to the conjunctiva.

Authors:  Jens Østergaard; Jannik Boberg-Ans; Jan Ulrik Prause; Steffen Heegaard
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-22       Impact factor: 3.117

5.  [Basal cell carcinoma of the periocular region].

Authors:  F Geszti; D Hargitai; O Lukáts; H Győrffy; J Tóth
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

6.  Gene networks in basal cell carcinoma of the eyelid, analyzed using gene expression profiling.

Authors:  Tatsuya Yunoki; Yoshiaki Tabuchi; Tetsushi Hirano; Shigeharu Miwa; Johji Imura; Atsushi Hayashi
Journal:  Oncol Lett       Date:  2018-09-21       Impact factor: 2.967

7.  5 years review of periocular basal cell carcinoma and proposed follow-up protocol.

Authors:  S F Ho; L Brown; M Bamford; R Sampath; J Burns
Journal:  Eye (Lond)       Date:  2012-11-16       Impact factor: 3.775

8.  Large eyelid basal cell carcinoma with uniform and diffuse melanin deposition.

Authors:  Saurabh Kamal; Ruchi Goel; Sushil Kumar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-07-20       Impact factor: 3.117

9.  Small margin excision of periocular basal cell carcinoma: 5 year results.

Authors:  J D Hsuan; R A Harrad; M J Potts; C Collins
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

10.  Surgery for primary basal cell carcinoma including the eyelid margins with intraoperative frozen section control: comparative interventional study with a minimum clinical follow up of 5 years.

Authors:  R M Conway; S Themel; L M Holbach
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.